Vesanoid and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Vesanoid (tretinoin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Piperacillin And Tazobactam, and have Acute promyelocytic leukaemia.

The phase IV clinical study analyzes which people have Abdominal pain when taking Vesanoid. It is created by eHealthMe based on reports of 1,361 people who have side effects when taking Vesanoid from the FDA, and is updated regularly.

What is Vesanoid?

Vesanoid has active ingredients of tretinoin. eHealthMe is studying from 1,366 Vesanoid users. Check the latest studies of Vesanoid.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,226 drugs and 5,744 conditions by eHealthMe. Check the latest studies of Abdominal pain.

On Apr, 24, 2026

1,361 people reported to have side effects when taking Vesanoid.
Among them, 23 people (1.69%) have Abdominal pain.

Among these 23 people:

How long have people been on Vesanoid when they have Abdominal pain? *

What is the gender of people who have Abdominal pain when taking Vesanoid? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Abdominal pain when taking Vesanoid? *

What are other drugs people take besides Vesanoid? *

Noxafil: 4 people, 17.39%
Piperacillin And Tazobactam: 4 people, 17.39%
Cytarabine: 3 people, 13.04%
Acetaminophen: 2 people, 8.70%
Allopurinol: 2 people, 8.70%
Daunorubicin Hydrochloride: 2 people, 8.70%
Pantoprazole: 2 people, 8.70%
Fluconazole: 1 person, 4.35%
Etoposide: 1 person, 4.35%
Enbrel: 1 person, 4.35%

What are other side effects people have besides Abdominal pain? *

Fever: 13 people, 56.52%
Diarrhea: 8 people, 34.78%
Intestinal Obstruction: 5 people, 21.74%
Alanine Aminotransferase Increased: 5 people, 21.74%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 21.74%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 21.74%
Dyspnea (difficult or laboured breathing): 5 people, 21.74%
Hydrocholecystis (distension of the gallbladder with watery fluid): 4 people, 17.39%
Chest Pain: 4 people, 17.39%
Indigestion: 3 people, 13.04%

What are the existing conditions these people have? *

Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 9 people, 39.13%
Infection: 4 people, 17.39%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 8.70%
Systemic Mycosis (fungal infections of the body): 1 person, 4.35%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.35%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
Groin Infection (infection in groin): 1 person, 4.35%
Gastric Ulcer (stomach ulcer): 1 person, 4.35%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Vesanoid and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vesanoid:

Vesanoid (1,366 reports)

Abdominal pain treatments and more:

Abdominal pain (286,410 reports)

Browse all side effects of Vesanoid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Abdominal pain (3,226 drugs)

Browse all the conditions that are associated with Abdominal pain:

Abdominal pain (5,744 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on tretinoin (the active ingredients of Vesanoid) and Vesanoid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.